Natural Capsules Approves Unaudited Results & Securities Allotment

Natural Capsules Ltd's Board of Directors met on November 13, 2026, to approve the unaudited consolidated and standalone financial results for the quarter and half-yearly ended September 2026. Additionally, the Board approved the preferential allotment of 1,12,500 equity shares at ₹178.00 per share, aggregating to ₹2,00,25,000, and 4,50,000 fully convertible warrants at ₹178.00 per warrant, aggregating to ₹8,01,00,000. These shares will rank pari-passu with existing equity shares. The meeting commenced at 2:30 PM and concluded at 6:30 PM.